Cytologic and immunocytochemical features of EBV negative primary effusion lymphoma: Report on seven Japanese cases

Diagnostic Cytopathology

Volumn 37, Issue 4, 2009, Pages 293-298

  Kishimoto, Koji ^a   Kitamura, Takashi ^a   Hirayama, Yoshiko ^a   Tate, Genshu ^a   Mitsuya, Toshiyuki ^a  

^a SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

Author keywords

BLIMP1; Cytomorphology; EVER; Human herpes virus 8; p16 CDKN2A; Post germinal center B cell; Primary effusion lymphoma

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; CD20 ANTIGEN; CD30 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; PROTEIN BCL 6; PROTEIN P16; SYNDECAN 1;

AGED; ARTICLE; CELL SIZE; CELL STRUCTURE; CHROMATIN; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLOGY; CYTOPLASM; EPSTEIN BARR VIRUS; FEMALE; GIEMSA STAIN; HUMAN; HUMAN HERPESVIRUS 8; IMMUNOBLASTIC LYMPHOMA; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; JAPANESE; LARGE CELL LYMPHOMA; MALE; MULTINUCLEAR CELL; MUTATION; PAPANICOLAOU TEST; PHENOTYPE; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL TIME;

AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, PRIMARY EFFUSION; MALE;

EID: 65349150653     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.21022     Document Type: Article

References (22)

1. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequence in AIDS-related body-cavity-based lymphomas. N Eng J Med 1995;332:1186-1191.
2. Jaffe ES, Harris NL, Stein H, Vardiman JW. World Health Organization classification of tumours, pathology and genetics, tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2001. p 179-180.
3. Brimo F, Michel RP, Khetani K, Auger M. Primary effusion lymphoma. A series of 4 cases and review of the literature with emphasis on cytomorphologic and immunocytochemical differential diagnosis. Cancer 2007;111:224-233.
4. Gaidano G, Carbone A. Primary effusion lymphoma: A liquid phase lymphoma of fluid-filled body cavities. Adv Cancer Res 2001;80: 115-146.
5. Suzuki K, Ino K, Sugawara Y, Mizutani M, Sekine T, Katayama N. Prolonged survival in a patient with human herpesvirus-8-negative primary effusion lymphoma after combination chemotherapy with rituximab. Gan To Kagaku Ryoho 2008;35:691-694.
6. Kishimoto K, Kitamura T, Fujita K, Tate G, Mitsuya T. Cytologic differential diagnosis of follicular lymphoma grades 1 and 2 from reactive follicular hyperplasia: Cytologic features of fine-needle aspiration smears with pap stain and fluorescence in situ hybridization analysis to detect t(14;18)(q32;q21) chromosomal translocation. Diagn Cytopatol 2006;34:11-17.
7. Kishimoto K, Kitamura T, Hirayama Y, Tate G, Mitsuya T. Three cases of extranodal NK/T-cell lymphoma of the nasal type diagnosed by nasal brush cytology. Diagn Cytopatol 2007;35:125-129.
8. Hirayama Y, Tate G, Kishimoto T, et al. Clonality assessment of T, NK/T-cell lymphoma-comparisons among primer sets and analyses of the limit to detect rearranged T-cell receptor-gamma genes. Jpn J Med Technol 2006;55:196-201 (In Japanese).
9. Carbone A, Gloghini A. PEL and HHV8-unrelated effusion lymphomas. Cancer (Cytopathology) 2008;114:225-227.
10. Takao T, Kobayashi Y, Kuroda J, et al. Rituximab is effective for human herpesvirus-8-negative primary effusion lymphoma with CD20 phenotype associated hepatitis C virus-related liver cirrhosis. Am J Hematol 2004;77:419-420.
11. Chiba H, Matsunaga T, Kuribayashi K, et al. Autoimmune hemolytic anemia as a first manifestation of primary effusion lymphoma. Ann Hematol 2003;82:773-776.
12. Fujiwara T, Ichinohasama R, Miura I, et al. Primary effusion lymphoma of the pericardial cavity carrying t(1;22)(q21;q11) and t(14;17)(q32;q23). Cancer Genet Cytogenet 2005;156:49-53.
13. Hisamoto A, Yamane H, Hiraki A, et al. Human herpes virus-8-negative primary effusion lymphoma in a patient with common variable immunodeficiency. Leuk Lymphoma 2003;44:2019-2022.
14. Inoue Y, Tsukasaki K, Nagai K, Soda H, Tomonaga M. Durable remission by sobuzoxane in an HIV-seronegative patient with human herpesvirus 8-negative primary effusion lymphoma. Int J Hematol 2004;79:271-275.
15. Matsumoto Y, Nomura K, Ueda K, et al. Human herpesvirus 8-negative malignant effusion lymphoma: A distinct clinical entity and successful treatment with rituximab. Leuk Lymphoma 2005;46:415- 419.
16. Nakamura Y, Tajima F, Omura H, Ishiga K, Kawatani T, Murawaki Y. Primary effusion lymphoma of the left scrotum. Intern Med 2003;42:351-353.
17. Nonami A, Yokoyama T, Takeshita M, Ohshima K, Kubota A, Okamura S. Human herpesvirus 8-negative primary effusion lymphoma (PEL) in patient after repeated chylous ascites and chylothorax. Intern Med 2004;43:236-242.
18. Shimazaki M, Fujita M, Tsukamoto K, et al. An unusual case of primary effusion lymphoma in a HIV-negative patient not pathogenetically associated with HHV8. Eur J Haematol 2003;71:62-67.
19. Tresnasari K, Takakuwa T, Ham MF, Ahadiani N, Nakajima H, Aozasa K. Teromerase dysfunction and inactivation of the p16 (INK4a)/Rb pathway in pyothorax-associated lymphoma. Cancer Sci 2007;98:978-984.
20. Carbone A, Gloghini A, Larocca LM, et al. Expression profile of MUM1/IRF4 BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas. Blood 2001;97:744-751.
21. Pasqualucci L, Compagno M, Houldsworth J, et al. Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma. J Exp Med 2006;203:311-317.
22. Tate G, Hirayama-Ohashi Y, Kishimoto K, Mitsuya T. Novel BLIMP1/PRDM1 gene mutations in B-cell lymphoma. Cancer Genet Cytogenet 2007;172:151-153.